Best Transarterial Radioembolization- TARE Treatment Hospitals Worldwide

Star Hospitals provides specialised Transarterial Radioembolization- TARE with a focus on precision, patient safety, and individualised cancer treatment. Established in 2008, the NABH, NABL hospital is located in Hyderabad, India, and operates 435 beds, equipped with modern healthcare infrastructure.

Transarterial Radioembolization (TARE) is a form of locoregional radiation therapy designed to target tumors within the liver while reducing radiation exposure to healthy tissue. It is commonly used for selected primary liver cancers and metastatic tumors involving the liver. The treatment typically involves catheter-based delivery of radioactive microspheres into the tumor's arterial blood supply. Comprehensive evaluation before treatment and follow-up imaging afterwards help doctors assess suitability, treatment response, and liver health.

Choosing Global Health City for Transarterial Radioembolization- TARE gives patients access to experienced interventional radiologists, advanced imaging technology, and multidisciplinary cancer care. Established in 1999, the NABH, NABL hospital in Chennai, India has 200 beds and provides specialised healthcare services.

Transarterial Radioembolization (TARE) is a minimally invasive procedure used to treat selected tumors located in the liver. During treatment, radioactive microspheres are delivered through a catheter into blood vessels supplying the tumor. The microspheres become lodged in the tumor's blood supply and release radiation over time. Patient selection generally involves detailed imaging, blood tests, and assessment of liver function before treatment, followed by monitoring and follow-up imaging.

At Fortis Malar Hospital, Transarterial Radioembolization- TARE is performed using advanced image-guided techniques and personalised treatment plans based on the patient's condition. Established in 1989, this NABH hospital in Chennai, India has 180 beds and provides comprehensive cancer care.

Transarterial Radioembolization (TARE) may be considered for patients with selected liver tumors, including hepatocellular carcinoma and certain metastatic cancers. The procedure involves guiding a catheter through the blood vessels to the liver and delivering radioactive microspheres directly into the arteries supplying the tumor. Patients usually undergo imaging and laboratory assessments before treatment to evaluate liver function and vascular anatomy. Follow-up care and imaging are used to monitor response and manage potential side effects.

nanavati Super Speciality Hospital offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 1950, the NABH hospital is located in Mumbai, India and has 350 beds, providing comprehensive care for local and international patients.

Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.

Rabin Medical Center is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 1996, the JCI hospital is situated in Petah Tikva, Israel and has 1300 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

At University Hospital, Transarterial Radioembolization- TARE is performed using advanced image-guided techniques and personalised treatment plans based on the patient's condition. Established in 1842, this SAC hospital in Basel, Switzerland has 773 beds and provides comprehensive cancer care.

Transarterial Radioembolization (TARE) may be considered for patients with selected liver tumors, including hepatocellular carcinoma and certain metastatic cancers. The procedure involves guiding a catheter through the blood vessels to the liver and delivering radioactive microspheres directly into the arteries supplying the tumor. Patients usually undergo imaging and laboratory assessments before treatment to evaluate liver function and vascular anatomy. Follow-up care and imaging are used to monitor response and manage potential side effects.

Choosing Hospital Quironsalud Barcelona for Transarterial Radioembolization- TARE gives patients access to experienced interventional radiologists, advanced imaging technology, and multidisciplinary cancer care. Established in 1944, the JCI, ISO hospital in Barcelona, Spain has 165 beds and provides specialised healthcare services.

Transarterial Radioembolization (TARE) is a minimally invasive procedure used to treat selected tumors located in the liver. During treatment, radioactive microspheres are delivered through a catheter into blood vessels supplying the tumor. The microspheres become lodged in the tumor's blood supply and release radiation over time. Patient selection generally involves detailed imaging, blood tests, and assessment of liver function before treatment, followed by monitoring and follow-up imaging.

Max Super Speciality Hospital, Patparganj is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2005, the NABH, NABL, AACI hospital is situated in Delhi, India and has 400 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

Choosing The London Clinic for Transarterial Radioembolization- TARE gives patients access to experienced interventional radiologists, advanced imaging technology, and multidisciplinary cancer care. Established in , the JCI hospital in London, United Kingdom has 234 beds and provides specialised healthcare services.

Transarterial Radioembolization (TARE) is a minimally invasive procedure used to treat selected tumors located in the liver. During treatment, radioactive microspheres are delivered through a catheter into blood vessels supplying the tumor. The microspheres become lodged in the tumor's blood supply and release radiation over time. Patient selection generally involves detailed imaging, blood tests, and assessment of liver function before treatment, followed by monitoring and follow-up imaging.

Burjeel Specialty Hospital, Sharjah provides specialised Transarterial Radioembolization- TARE with a focus on precision, patient safety, and individualised cancer treatment. Established in 2019, the JCI hospital is located in Sharjah, United Arab Emirates, and operates 75 beds, equipped with modern healthcare infrastructure.

Transarterial Radioembolization (TARE) is a form of locoregional radiation therapy designed to target tumors within the liver while reducing radiation exposure to healthy tissue. It is commonly used for selected primary liver cancers and metastatic tumors involving the liver. The treatment typically involves catheter-based delivery of radioactive microspheres into the tumor's arterial blood supply. Comprehensive evaluation before treatment and follow-up imaging afterwards help doctors assess suitability, treatment response, and liver health.

Ekol is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2000, the ISO hospital is situated in Izmir, Turkey and it has adequate bed capacity.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

Choosing Werndale Hospital for Transarterial Radioembolization- TARE gives patients access to experienced interventional radiologists, advanced imaging technology, and multidisciplinary cancer care. Established in 1991, the hospital in Carmarthen, United Kingdom has 19 beds and provides specialised healthcare services.

Transarterial Radioembolization (TARE) is a minimally invasive procedure used to treat selected tumors located in the liver. During treatment, radioactive microspheres are delivered through a catheter into blood vessels supplying the tumor. The microspheres become lodged in the tumor's blood supply and release radiation over time. Patient selection generally involves detailed imaging, blood tests, and assessment of liver function before treatment, followed by monitoring and follow-up imaging.

Arab Medical Center is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 1997, the JCI hospital is situated in Amman, Jordan and has 243 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

Ara Damansara Medical Centre provides specialised Transarterial Radioembolization- TARE with a focus on precision, patient safety, and individualised cancer treatment. Established in 2012, the JCI, MSQH hospital is located in Kuala Lumpur, Malaysia, and operates 220 beds, equipped with modern healthcare infrastructure.

Transarterial Radioembolization (TARE) is a form of locoregional radiation therapy designed to target tumors within the liver while reducing radiation exposure to healthy tissue. It is commonly used for selected primary liver cancers and metastatic tumors involving the liver. The treatment typically involves catheter-based delivery of radioactive microspheres into the tumor's arterial blood supply. Comprehensive evaluation before treatment and follow-up imaging afterwards help doctors assess suitability, treatment response, and liver health.

Max Super Speciality Hospital, Saket offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 2006, the JCI, NABH hospital is located in Delhi, India and has 539 beds, providing comprehensive care for local and international patients.

Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.